Abstract:ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to "A Carrier-Free Nanomedicine Enables Apoptosis-Ferroptosis Synergistic Breast Cancer Therapy by Targeting Subcellular Organelles"Jiaxin ZhuJiaxin ZhuDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Jiaxin Zhu, Kexin ZhangKexin ZhangDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Kexin Zhang, Ya ZhouYa ZhouDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Ya Zhou, Ruyi WangRuyi WangDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Ruyi Wang, LiangPing GongLiangPing GongDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by LiangPing Gong, Can WangCan WangDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Can Wang, Keke ZhongKeke ZhongDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Keke Zhong, Wenyuan LiuWenyuan LiuDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 211198, ChinaKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical Unrsity, Nanjingive 211198, ChinaMore by Wenyuan Liuhttps://orcid.org/0000-0002-2536-9416, Feng Feng*Feng FengNanjing Medical University, Nanjing 211198, ChinaDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Feng Feng, and Wei Qu*Wei QuDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Wei Quhttps://orcid.org/0000-0003-2075-9033Cite this: ACS Appl. Mater. Interfaces 2023, 15, 24, 29653Publication Date (Web):June 9, 2023Publication History Received21 May 2023Published online9 June 2023Published inissue 21 June 2023https://pubs.acs.org/doi/10.1021/acsami.3c06803https://doi.org/10.1021/acsami.3c06803correctionACS PublicationsCopyright © 2023 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views479Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (798 KB) Get e-Alertsclose Get e-Alerts

Correction to “renal Clearable Bi–Bi2S3 Heterostructure Nanoparticles for Targeting Cancer Theranostics”

Correction to Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release

Correction to High F-Content Perfluoropolyether-Based Nanoparticles for Targeted Detection of Breast Cancer by 19F Magnetic Resonance and Optical Imaging

Correction to “Single-Molecular Near-Infrared-II Theranostic Systems: Ultrastable Aggregation-Induced Emission Nanoparticles for Long-Term Tracing and Efficient Photothermal Therapy”

Correction to Intracellular Fate of Nanoparticles with Polydopamine Surface Engineering and a Novel Strategy for Anti-Exocytosis Enhanced, Lysosome Impairment-Based Cancer Therapy

Correction to “Active-Targeting NIR-II Phototheranostics in Multiple Tumor Models Using Platelet-Camouflaged Nanoprobes”

Correction to “enhanced Sensitivity of Cancer Stem Cells to Chemotherapy Using Functionalized Mesoporous Silica Nanoparticles”

Correction to "Diketopyrrolopyrrole-Triphenylamine Organic Nanoparticles As Multifunctional Reagents for Photoacoustic Imaging-Guided Photodynamic/Photothermal Synergistic Tumor Therapy".

Correction to “Nir-Activated Polymeric Nanoplatform with Upper Critical Solution Temperature for Image-Guided Synergistic Photothermal Therapy and Chemotherapy”

Correction to “A Carrier-Free Nanomedicine Enables Apoptosis-Ferroptosis Synergistic Breast Cancer Therapy by Targeting Subcellular Organelles”

Correction to Receptor and Microenvironment Dual-Recognizable Nanogel for Targeted Chemotherapy of Highly Metastatic Malignancy

Correction to Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy

Correction to Charge-Convertible Carbon Dots for Imaging-Guided Drug Delivery with Enhanced in Vivo Cancer Therapeutic Efficiency

Correction to “highly Biocompatible Chlorin E6-Loaded Chitosan Nanoparticles for Improved Photodynamic Cancer Therapy”

Correction to Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma

Correction to “Cu2+-Loaded Polydopamine Nanoparticles for Magnetic Resonance Imaging-Guided Ph- and Near-Infrared-Light-Stimulated Thermochemotherapy”

Correction to Cooperatively Responsive Peptide Nanotherapeutic That Regulates Angiopoietin Receptor Tie2 Activity in Tumor Microenvironment to Prevent Breast Tumor Relapse after Chemotherapy

Correction to Cisplatin-Cross-Linked and Oxygen-Resupply Hyaluronic Acid-Based Nanocarriers for Chemo-photodynamic Therapy

Correction to “Self-Propelled Gemini-like LMWH-Scaffold Nanodrugs for Overall Tumor Microenvironment Manipulation via Macrophage Reprogramming and Vessel Normalization”

Correction to Multifunctional Microspheres Encoded with Upconverting Nanocrystals and Magnetic Nanoparticles for Rapid Separation and Immunoassays

Correction to “magnetic and Folate Functionalization Enables Rapid Isolation and Enhanced Tumor-Targeting of Cell-Derived Microvesicles”